We next investigated whether targeted LNPs could deliver FAPCAR mRNA (CD5/LNP-FAPCAR)to T cells in an established murine hypertensive model of cardiac injury and fibrosis produced by constant infusion of angiotensin II/phenylephrine (AngII/PE) through implanted 28-dayosmoticmini-pumps